These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31993575)

  • 1. Optimal doses of antidepressants in dependence on age: Combined covariate actions in Bayesian network meta-analysis.
    Holper L
    EClinicalMedicine; 2020 Jan; 18():100219. PubMed ID: 31993575
    [No Abstract]   [Full Text] [Related]  

  • 2. Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
    Kishi T; Ikuta T; Sakuma K; Okuya M; Hatano M; Matsuda Y; Iwata N
    Mol Psychiatry; 2023 Jan; 28(1):402-409. PubMed ID: 36253442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
    Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
    Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: protocol for a systematic review and networkmeta-analysis.
    Shinohara K; Efthimiou O; Ostinelli EG; Tomlinson A; Geddes JR; Nierenberg AA; Ruhe HG; Furukawa TA; Cipriani A
    BMJ Open; 2019 May; 9(5):e027574. PubMed ID: 31110100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side effect profile and comparative tolerability of 21 antidepressants in the acute treatment of major depression in adults: protocol for a network meta-analysis.
    Tomlinson A; Efthimiou O; Boaden K; New E; Mather S; Salanti G; Imai H; Ogawa Y; Tajika A; Kishimoto S; Kikuchi S; Chevance A; Furukawa TA; Cipriani A
    Evid Based Ment Health; 2019 May; 22(2):61-66. PubMed ID: 30996028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial and harmful effects of antidepressants versus placebo, 'active placebo', or no intervention for adults with major depressive disorder: a protocol for a systematic review of published and unpublished data with meta-analyses and trial sequential analyses.
    Juul S; Siddiqui F; Barbateskovic M; Jørgensen CK; Hengartner MP; Kirsch I; Gluud C; Jakobsen JC
    Syst Rev; 2021 May; 10(1):154. PubMed ID: 34034811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence synthesis, practice guidelines and real-world prescriptions of new generation antidepressants in the treatment of depression: a protocol for cumulative network meta-analyses and meta-epidemiological study.
    Luo Y; Chaimani A; Kataoka Y; Ostinelli EG; Ogawa Y; Cipriani A; Salanti G; Furukawa TA
    BMJ Open; 2018 Dec; 8(12):e023222. PubMed ID: 30530583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining threshold analysis and GRADE to assess sensitivity to bias in antidepressant treatment recommendations adjusted for depression severity.
    Holper L
    Res Synth Methods; 2020 Mar; 11(2):275-286. PubMed ID: 31873975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis.
    Furukawa TA; Salanti G; Atkinson LZ; Leucht S; Ruhe HG; Turner EH; Chaimani A; Ogawa Y; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Suganuma A; Watanabe N; Stockton S; Geddes JR; Cipriani A
    BMJ Open; 2016 Jul; 6(7):e010919. PubMed ID: 27401359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis.
    Furukawa TA; Cipriani A; Cowen PJ; Leucht S; Egger M; Salanti G
    Lancet Psychiatry; 2019 Jul; 6(7):601-609. PubMed ID: 31178367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
    Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P
    Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indices of Change, Expectations, and Popularity of Biological Treatments for Major Depressive Disorder between 1988 and 2017: A Scientometric Analysis.
    Tran BX; Ha GH; Vu GT; Nguyen LH; Latkin CA; Nathan K; McIntyre RS; Ho CS; Tam WW; Ho RC
    Int J Environ Res Public Health; 2019 Jun; 16(13):. PubMed ID: 31247926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
    Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI
    J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Antidepressants in Combination with Psychotherapy.
    Alemi F; Soylu TG; Cannon M; McCandless C
    J Ment Health Policy Econ; 2024 Mar; 27(1):3-12. PubMed ID: 38634393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative efficacy and acceptability of new-generation antidepressants. Synthesis meta-analysis Cipriani].
    Gaillard R
    Encephale; 2009 Oct; 35(5):499-504. PubMed ID: 19853726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
    Favré P
    Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials.
    Hayasaka Y; Purgato M; Magni LR; Ogawa Y; Takeshima N; Cipriani A; Barbui C; Leucht S; Furukawa TA
    J Affect Disord; 2015 Jul; 180():179-84. PubMed ID: 25911132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis.
    Oliva V; Lippi M; Paci R; Del Fabro L; Delvecchio G; Brambilla P; De Ronchi D; Fanelli G; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul; 109():110266. PubMed ID: 33549697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.
    Cipriani A; Furukawa TA; Salanti G; Geddes JR; Higgins JP; Churchill R; Watanabe N; Nakagawa A; Omori IM; McGuire H; Tansella M; Barbui C
    Lancet; 2009 Feb; 373(9665):746-58. PubMed ID: 19185342
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.